Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Remember Napster? Now It’s Making a Wild AI Comeback
Napster CEO John Acunto explains how the iconic brand is reinventing itself as an AI company using video agents to transform customer experiences.
Meta Is Paying Billions: What Exactly Is The Company Agreeing To?
Tyler Katzenberger, Technology Reporter at POLITICO, breaks down what Meta is agreeing to in its multibillion-dollar settlements and why they matter.
Why These People Made the TIME100 AI List
Ayesha Javed, senior editor at TIME, takes us inside the selection and explains what the list reveals about the future of artificial intelligence.
Why Everyone Went Back to the Movies This Summer
Screen Engine CEO Kevin Goetz reveals what audience research says about Hollywood’s surprising 2026 box-office rebound.
Is Whatnot Turning Shopping into Gambling? Inside the App’s Addictive Live Auctions
Hanna Krueger, Wall Street Journal reporter, examines Whatnot’s fast-paced auctions, impulse spending and gambling-like shopping experience.
Hawkeye 360’s Space Intelligence Boom: Revenue Surges 87% As Demand Takes Off
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
